Clinical Efficacy of Novel Jasminum-based Calcium Hydroxide Medicament
Status:
COMPLETED
Trial end date:
2024-09-25
Target enrollment:
Participant gender:
Summary
A triple-blind, parallel group, randomized trial with an allocation ratio of 1:1. Participants randomly allocated into two groups A and B. In group A, nano-reinforced calcium hydroxide medicament was utilized while in group B, calcium hydroxide medicament without nanoparticles was used. Post-operative pain was assessed after 4 hours, 24 hours, 48 hours, 72 hours, 96 hours.